AN UNBIASED VIEW OF ARTHRITIS & RHEUMATOLOGY JOURNAL

Because of significant innovations from the pharmaceutical sector, new therapeutic ways can be found. However, The dearth of understanding of the molecular mechanisms governing the fate of antibodies leads to a problem in order to find a curative cure. The most effective therapeutic solution calls for early prognosis and an ideal nonpharmacological